Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Interference with RhoA-ROCK Signaling Mechanism in Autoreactive CD4(+) T Cells Enhances the Bioavailability of 1,25-Dihydroxyvitamin D(3) in Experimental Autoimmune Encephalomyelitis.
The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse.
English Court of Appeal finds in favor of Teva on Copaxone(R) patent litigation and upholds validity of Copaxone patent until May 2015
Retrospective US database analysis of persistence with glatiramer acetate vs. available disease-modifying therapies for multiple sclerosis: 2001-2010.
Fatigue, depression and sleep disturbances in Iranian patients with multiple sclerosis.
First-line natalizumab in multiple sclerosis: rationale, patient selection, benefits and risks.
A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - A twelve month follow-up.
Targeted ablation of oligodendrocytes induces axonal pathology independent of overt demyelination.
Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel.
Increase in NF-κB-sensitive miRNA-146a and miRNA-155 in multiple sclerosis (MS) and pro-inflammatory neurodegeneration.
Mapi Pharma Receives Additional Claims for Its U.S. Patent for Glatiramer Acetate Depot for the Treatment of Multiple Sclerosis
HERV-W envelope protein inhibits oligodendroglial precursor cell differentiation.
Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis - a review.
Peripheral accumulation of newly produced T and B lymphocytes in natalizumab-treated multiple sclerosis patients.
Novel Immune Regulator Shows Promise as MS Therapy in Clinical Trials
Cutaneous and pulmonary sarcoidosis following treatment of multiple sclerosis with interferon-beta-1b: a case report.
Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation.
Long-term effects of dalfampridine in patients with multiple sclerosis.
The extent of ultrastructural spinal cord pathology reflects disease severity in experimental autoimmune encephalomyelitis.
Artielle Immunotherapeutics Announces Positive Results of Phase ! Multiple Sclerosis Trial
Myasthenia gravis and neuromyelitis optica spectrum disorder: A multicenter study of 16 patients.
Higher Relative Risk for Multiple Sclerosis in a Pediatric and Adolescent Diabetes Population: Analysis From DPV Data Base.
Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis.
Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
Serum pharmacokinetics and cerebrospinal fluid concentration analysis of the new IgG4 monoclonal antibody GNbAC1 to treat multiple sclerosis: a Phase 1 study.

Pages